Original Research
Published on 03 May 2022
Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.833486
- 3,602 views
- 5 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,601 articles
Articles
Original Research
Published on 03 May 2022
Deciphering the Role of Shugoshin-Like Protein 1 in Lung Adenocarcinoma: A Comprehensive Analysis and In Vitro Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.898920
- 1,924 views
- 3 citations
Original Research
Published on 03 May 2022
Gut Microbiome Was Highly Related to the Regulation of Metabolism in Lung Adenocarcinoma Patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.790467
- 3,271 views
- 6 citations
Review
Published on 02 May 2022
Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.886430
- 2,497 views
- 4 citations
Systematic Review
Published on 29 Apr 2022
Differential Diagnostic Value of Histology in MPLC and IPM: A Systematic Review and Meta-Analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.871827
- 9,368 views
- 7 citations
Original Research
Published on 29 Apr 2022
CDC25C as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.867788
- 2,595 views
- 9 citations
Original Research
Published on 28 Apr 2022
The Difference and Significance of Parietal Pleura Invasion and Rib Invasion in Pathological T Classification With Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.878482
- 2,225 views
- 7 citations
Original Research
Published on 28 Apr 2022
A Multi-Classification Model for Predicting the Invasiveness of Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodules
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.800811
- 2,517 views
- 7 citations
Brief Research Report
Published on 28 Apr 2022
Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.836751
- 1,927 views
- 2 citations
Original Research
Published on 28 Apr 2022
CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.822849
- 5,022 views
- 9 citations
Brief Research Report
Published on 28 Apr 2022
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.834704
- 10,201 views
- 33 citations
Original Research
Published on 27 Apr 2022
MR-Guided Microwave Ablation for Lung Malignant Tumor: A Single Center Prospective Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.856340
- 2,196 views
- 5 citations
Original Research
Published on 26 Apr 2022
Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.879554
- 1,543 views
- 1 citation
Original Research
Published on 22 Apr 2022
The Predictive Value of PD-L1 Expression Level in Evaluating the Cost-Effectiveness of Atezolizumab/Pembrolizumab
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.857452
- 2,710 views
- 1 citation
Case Report
Published on 21 Apr 2022
Case Report: Durable Response to the Combination of Brigatinib and Cetuximab Plus Icotinib in a NSCLC Patient Harboring EGFR L858R-T790M-cis-G796S and L718Q Resistance Mutations Following Progression With Osimertinib
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.875313
- 2,736 views
- 6 citations
Review
Published on 20 Apr 2022
A Review of the Correlation Between Epidermal Growth Factor Receptor Mutation Status and 18F-FDG Metabolic Activity in Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.780186
- 2,636 views
- 9 citations